Recerca

Àrea 4

Neuroimmunologia clínica i experimental

Articles de l'any 2010
Original

Originals publicats: 19

Factor d'impacte: mitjana: 5.2, total: 98.76

  • THE EXPANDING CLINICAL PROFILE OF ANTI-AMPA RECEPTOR ENCEPHALITIS

    Graus F, Boronat A, Xifro X, Boix M, Svigelj V, Garcia A, Palomino A, Sabater L, Alberch J, Saiz A
    NEUROLOGY. 2010; 74: 857-859. IF: 8.172

  • Metabotropic Glutamate Receptor Type 1 Autoantibody-Associated Cerebellitis A Primary Autoimmune Disease?

    Marignier R, Chenevier F, Rogemond V, Smitt PS, Renoux C, Cavillon G, Androdias G, Vukusic S, Graus F, Honnorat J, Confavreux C
    ARCH NEUROL-CHICAGO. 2010; 67: 627-630. IF: 6.312

  • Paraneoplastic Neurologic Syndrome in the PNS Euronetwork Database A European Study From 20 Centers

    Giometto B, Grisold W, Vitaliani R, Graus F, Honnorat J, Bertolini G
    ARCH NEUROL-CHICAGO. 2010; 67: 330-335. IF: 6.312

  • Fractal-dimension analysis detects cerebral changes in preterm infants with and without intrauterine growth restriction

    Esteban FJ, Padilla N, Sanz-Cortes M, DeMiras JR, Bargallo N, Villoslada P, Gratacos E
    NEUROIMAGE. 2010; 53: 1225-1232. IF: 5.739

  • Delayed onset of a second paraneoplastic neurological syndrome in eight patients

    Ducray F, Graus F, Vigliani MC, Antoine JC, Rogemond V, Saiz A, Honnorat J
    J NEUROL NEUROSUR PS. 2010; 81: 937-939. IF: 4.869

Revisió

Revisions publicades: 2

Factor d'impacte: mitjana: 3.09, total: 6.18

  • The therapeutic potential of mesenchymal stem cell transplantation as a treatment for multiple sclerosis: consensus report of the International MSCT Study Group

    Freedman MS, Bar-Or A, Atkins HL, Karussis D, Frassoni F, Lazarus H, Scolding N, Slavin S, LeBlanc K, Uccelli A
    MULT SCLER. 2010; 16: 503-510. IF: 3.279

  • Antibodies and neuronal autoimmune disorders of the CNS

    Graus F, Saiz A, Dalmau J
    J NEUROL. 2010; 257: 509-517. IF: 2.903

Multicèntrics

Multicèntrics publicats: 1

Factor d'impacte: mitjana: 3.28, total: 3.28

  • Rapid benefits of a new formulation of subcutaneous interferon beta-1a in relapsing-remitting multiple sclerosis

    DeStefano N, Curtin F, Stubinski B, Blevins G, Drulovic J, Issard D, Shotekov P, Gasperini C
    MULT SCLER. 2010; 16: 888-892. IF: 3.279

Més articles